1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Mumps: new trials by email Literature Review of Mumps trials Research Report on Mumps
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age MMRVNS vaccine, MMRV vaccine, DTaP-IPV vaccine - Measles, Mumps | Phase 3 | Not yet recruiting | GlaxoSmithKline | 1860 | 2026-08-11 | 2026-08-03 |
Chickenpox (1) · Measles (1) · Rubella (1)
DNA Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Mononegavirales Infections (1) · Morbillivirus Infections (1) · Mouth Diseases (1) · Paramyxoviridae Infections (1) · Parotid Diseases (1) · Parotitis (1) · RNA Virus Infections (1) · Rubivirus Infections (1) · Rubulavirus Infections (1) · Salivary Gland Diseases (1) · Stomatognathic Diseases (1) · Togaviridae Infections (1)
DTPP vaccine (1) · measles, mumps, rubella, varicella vaccine (1)
GlaxoSmithKline (1)
Argentina (1) · Finland (1) · Italy (1) · Puerto Rico (1) · Taiwan (1) · United States (1)
2025 (1)